Persistent Asset Partners LTD Bridge Bio Pharma, Inc. Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 572 shares of BBIO stock, worth $21,930. This represents 0.22% of its overall portfolio holdings.
Number of Shares
572Holding current value
$21,930% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$846 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$738 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$571 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$477 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$275 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.68B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...